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INTRODUCTION 
 Ischemic heart disease is still one of the most serious problems facing modern 
cardiology and remains one of the leading causes of death in the developed countries. 
Coronary angiography is the standard procedure for assessing the severity of coronary artery 
stenosis; however, important limitations of coronary angiography has been clearly described 
(1-3) opening the door for invasive complimentary technologies such as intravascular 
ultrasound (IVUS) and fractional flow reserve (FFR) to improve accuracy in the assessment 
of coronary lesions. Intravascular ultrasound (IVUS) is a widely-used invasive method that 
provides accurate data about the dimensions of the lumen and wall of the vessels, and 
adequately visualizes the pathological changes of the endothelium (4). IVUS and pressure 
wire derived FFR measurements are the most common procedures used to assess the severity 
of borderline coronary stenosis (5,6). Although IVUS provides detailed anatomical 
information on the vessel lumen, it is an expensive and invasive procedure.  In many cases, 
the planar 2-D silhouette of the arterial lumen may be unable to accurately define the severity 
of coronary stenosis, regardless of whether visual or quantitative methods are used (7). 
Myocardial blood flow is regulated at the level of the coronary arterioles. If myocardial 
oxygen consumption increases, coronary flow resistance decreases due to vasodilatation, thus 
increasing myocardial blood flow. Absolute flow reserve is defined as the ratio of hyperaemic 
to resting flow. When a flow-limiting stenosis is present, the dilatation of the distal 
microvasculature ensures proper and sufficient resting blood flow, but the maximum 
hyperaemic flow might be insufficient during exercise; in this case, the ratio of hyperaemic to 
resting flow is less than two. Several methods are used to measure coronary flow reserve 
(CFR). Invasive methods include intracoronary Doppler guidewire and intracoronary 
thermodilution (8-10); non-invasive methods include transesophageal echocardiography 
(11,12) and transthoracic echocardiography (13-15). Other procedures, such as positron 
emission tomography, are not widely available and/or are expensive (16). 
The transradial approach to coronary, peripheral angiograpraphy and angioplasty has become 
a popular technique, however the place of the technique was questioned in the literature for 
the treatment of myocardial infarction and for carotid artery stenting.  
 
THE PATHOPHYSIOLOGY OF MYOCARDIAL ISCHAEMIA 
1. Coronary circulation 
Although the heart chambers are filled with blood, it provides very little nourishment and 
oxygen to the tissues of the heart. The walls of the heart are too thick to be supplied by 
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diffusion alone. Instead, the tissues of the heart are supplied by a separate vascular supply 
committed only to the heart. The arterial supply to the heart arises from the base of the aorta 
as the right and left coronary arteries (running in the coronary sulcus). The venous drainage is 
via cardiac veins that return deoxygenated blood to the right atrium. The coronary arteries 
arise from the Ostia in the left and right sinuses of the aortic semilunar valve, course within 
the epicardium, and encircle the heart in the atrioventricular (coronary) and interventricular 
sulci. The coronary circulation supplies the heart with oxygen and nutrients to maintain 
cardiac function and thus supply the remainder of the body with blood. The systemic 
metabolic needs may change rapidly and widely, thus requiring adaptation of cardiac function 
and coronary blood flow. Imbalance in myocardial oxygen demand and supply can produce 
myocardial ischemia with contractile cardiac dysfunction, arrhythmias, infarction, and 
possible death. The flow throw the coronary artery is pulsatile, with characteristic phasic 
systolic and diastolic flow components. Systolic compression of the intramural coronary 
vessels causes mean systolic arterial flow to be reduced relative to diastolic flow, despite 
having a higher systolic driving pressure.  The systolic flow wave has rapid, brief retrograde 
responses corresponding to phasic myocardial compliance over the cardiac cycle. Diastolic 
flow occurs during the relaxation phase after myocardial contraction with an abrupt increase 
above systolic levels and a gradual decline parallel with that of aortic diastolic pressure. 
Coronary venous flow is out of phase with coronary arterial flow, occurring predominantly in 
systole and nearly absent during diastole. The arterial and venous pulsatile flow 
characteristics describing the heart as a pump dependent on intramyocardial resistance. The 
intramyocardial capillary resistance influences both arterial and venous responses but 
predominantly acts in concert with outlet resistance. The coronary blood flow not only is 
phasic but also varies with the type of vessel and location in the myocardium. The nonlinear 
and time-dependent behaviour of the coronary flow may not be the neglible under specific 
experimental or clinical conditions. 
Myocardial oxygen supply and demand relationship: The basic concept of the myocardial 
supply and demand relationship is that for any given oxygen need, the heart will supplied with 
a sufficient quantity to prevent underperfusion leading to ischemia or infarction. Myocardial 
oxygen demand (MVO2) has been indexed by the product of systolic aortic pressure and 
systolic duration. Myocardial oxygen supply (flow) can be indexed by the product of diastolic 
time and mean diastolic pressure. The heart, an aerobic organ, relies almost exclusively on the 
oxidation of substrates for energy generation. It can develop only a small oxygen debt. In a 
steady state, MVO2 provides an accurate measure of its total metabolism. MVO2 correlates 
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with the fraction of energy derived from the metabolism of fatty acids, which varies directly 
with the arterial concentration of fatty acids and inversely with that of glucose and insulin. 
The total metabolism of the arrested, quiescent heart is only a small fraction of that of the 
working organ.   
Determinants of myocardial oxygen demand: The three major determinants of the MVO2 
are heart rate, myocardial contractility, and myocardial wall tension or stress (17).  
Determinants of myocardial oxygen supply: Oxygen transport and delivery: Satisfactory 
oxygen transport and delivery require an adequate inspired quantity of oxygen and red blood 
cells with normally functioning haemoglobins. Hypoxia from pneumonia or carbon monoxide 
overdose, anaemia, or hemoglobinopathies can produce myocardial ischemia despite adequate 
coronary blood flow. Regulation of coronary blood flow and resistance: Approximately 75 
percent of total coronary resistance occurs in the arterial system, which comprises 
conductance (R1), prearteriolar (R2), and arteriolar and myocardial capillary vessels (R3) 
(18).  
Myocardial ischemia: Coronary artery disease is almost always due to athermatous 
narrowing and subsequent occlusion of the vessel. Early atheroma (from the Greek athera 
(porridge) and oma (lump)) is present from young adulthood onwards. A mature plaque is 
composed of two constituents, each associated with a particular cell population. The lipid core 
is mainly released from necrotic “foam cells”—monocyte derived macrophages, which 
migrate into the intima and ingest lipids. The connective tissue matrix is derived from smooth 
muscle cells, which migrate from the media into the intima, where they proliferate and change 
their phenotype to form a fibrous capsule around the lipid core. When a plaque produces a > 
50% diameter stenosis (or > 75% reduction in cross sectional area), reduced blood flow 
through the coronary artery during exertion may lead to angina. The basic definition of 
myocardial ischemia is a greater myocardial tissue oxygen demand than oxygen supply. 
Anatomically, the most vulnerable layer of the heart is the subendocardium; because of the 
higher systolic wall stress in this layer compared to the mid- and epicardial layers, there exists 
a relatively greater metabolic demand. Coronary flow reserve (CFR), the capacity to increase 
coronary flow over basal levels, is normally about threefold in sedentary adults but can be six 
fold in world-class endurance athletes. Normally coronary blood flow can increase 
approximately four-to-six fold to meet increasing myocardial oxygen demands. This effect is 
mediated by vasodilation at the arteriolar bed, which reduces vascular resistance, thereby 
augmenting flow. The coronary reserve (CFR) represents the capacity of the coronary 
circulation to dilate following an increase in myocardial metabolic demands and can be 
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expressed by the difference between the hyperemic flow and the resting flow curve. In 1974, 
Lance K Gould (19) proposed the relationship between  the anatomic condition and behaviour 
of coronary hyperaemic flow, whereby an inverse curvilinear relationship exists between the 
narrowing of lumen of coronary artery and hyperaemic capability, up to a completely 
abolished coronary reserve for stenosis >90%. This experimental paradigm can be accurately 
reproduced clinically in highly selected series of patients with single vessel disease, no 
myocardial infarction, no coronary collateral circulation, normal baseline function, no left 
ventricular hypertrophy, without evidence of coronary vasospasm, and off therapy at the time 
of testing. The perfect, predictable relationship found in the experimental animal or in a very 
selected patient population (20) is not so perfect in clinical practice (21,22), where many 
variables can modulate the imperfect match between epicardial coronary artery.  stenosis and 
coronary flow reserve, such as the geometric characteristics of the stenosis, the presence of 
coronary collateral circulation, the microvascular component of coronary resistance, the 
presence of left ventricular hypertrophy modulating the myocardial extravascular component 
of coronary resistance, the viable or necrotic state of the myocardium distal to the stenosis, the 
presence of coronary macrovascular or microvascular spasm, and, last but not least, the 
presence of concomitant antiischemic therapy. CFR is a useful way to assess the physiological 
impact of coronary stenosis and the outcome of revascularization by coronary angioplasty or 
coronary artery bypass surgery. With either a pressure-monitoring or Doppler flow velocity 
wire one can measure the maximum pressure or coronary flow in comparison with the aortic 
response to the systemic administration of a vasodilator such as adenosine. Obstructions 
reducing coronary luminal diameter by less than 40% do not affect CFR, but reductions of 
>80% exhaust vasodilator reserve (23) (Coronary lesions less than 80% may show a poor 
vasodilator reserve response and therefore are candidates for angioplasty). Although the 
pressure and flow methods appear to have equivalent clinical value, the pressure 
measurements give additional information. Coronary artery “wedge” pressure distal to an 
inflated angioplasty balloon is normally less than 25% of aortic pressure; higher pressures 
reflect coronary collateral development (24). 
 
VISUALISATION OF THE CORONARY ARTERIES WITH ULTRASOUND 
1. Transthoracic echocardiography 
Transthoracic Doppler echocardiography (TTDE) has been introduced as a new diagnostic 
approach to visualize coronary blood flow and measure CFR non-invasively for the LMCA, 
LAD (11-15, 25-28) and of the distal right coronary artery (29). TTDE for non-invasive 
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assessment of CFR provides useful quantitative information regarding the functional status of 
coronary arteries. In combination with coronary morphologic findings obtained from cardiac 
catheterization, CFR has relevant clinical implications for patients scheduled for invasive 
evaluation and treatment of coronary artery disease. TDE CFR assessment in the LAD and 
RDP of the right coronary artery closely agrees with invasive measurements (11-15, 25-29). 
 
 
Figure 1. During TTE with pulsed-Doppler measurements (Toshiba Powervision 8000, 
Tokyo, Japan), significant increase in coronary flow velocities in distal LM after appropriate 
angle correction could be demonstrated.  
 
2. Transoesophageal echocardiography and CFR measurement 
Up to now, coronary flow reserve has been evaluated invasively in the cath. lab and  in 
nuclear medicine through perfusion  imaging. Only recently has coronary flow reserve entered 
the echo lab, with the combination of coronary flow assessment by Doppler and vasodilator 
stress. With either TEE (sampling proximal tract) or TTE (exploring mid-distal tract) the 
coronary blood flow velocity profile recorded with pulsed wave Doppler is consistent with the 
pathophysiological premises. Accordingly, coronary flow velocity by Doppler assessment 
appears to be biphasic, with a lower peak during systole and a higher peak during diastole 
(Figure 1). Myocardial extravascular resistance is higher in systole and lower in diastole due 
to the effect of myocardial contraction. The flow velocity variations are proportional to the 
total blood flow if the vessel lumen is kept constant, a reasonable assumption with the 
administration of drugs such as dipyridamole or adenosine. The coronary flow velocity 
variation between the baseline and peak effect of a coronary vasodilator allows a coronary 
flow reserve index in the left anterior descending artery territory to be derived. Peak diastolic 
flow is the simplest parameter to be measured and the most easily obtained, in addition to 
being the most reproducible and the one with the closest correlation with coronary perfusion 
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reserve measured by positron emission tomography. The coronary flow signal on LAD was 
first made possible by TEE with excellent diagnostic results but only more recently has there 
been an increase in clinical interest due to the development of the transthoracic method. There 
were technological factors which allowed the totally noninvasive transthoracic imaging of 
mid-distal LAD of the vessel. The estimated flow reserve can be accurate if the coronary 
functions only as a conduit, without changing in diameter during drug infusion. This 
assumption is reasonable with dipyridamole and less valid with dobutamine: this is an 
additional reason to stress coronary flow reserve with vasodilators.  
 
 
Figure 1. shows  increase in PDV in the proximal LAD during iv. dypiridamole (Rest 
velocity: 53 mm/s, Peak velocity 120 mm/s, calculated CFR 2.26) 
 
Coronary flow reserve: a new diagnostic tool The use of CFR as a "stand-alone" diagnostic 
criterion suffers from so many structural limitations as to make it little more than an academic 
somersault: firstly, only LAD is sampled; secondly, the coronary flow reserve cannot 
distinguish between microvascular and macrovascular coronary disease. Therefore, it is much 
more interesting (and clinically realistic) to evaluate the additive value over conventional wall 
motion for LAD detection. The assessment of CFR adds sensitivity for LAD disease – with a 
modest loss in specificity. In reality, the inherently quantitative information of LAD flow 
reserve allows a stratification of the response, integrating many different tests into one: 
greatly reduced CFR (<1.5) yields extraordinary specificity whilst mildly reduced CFR (<2.0) 
offers outstanding sensitivity. In addition, the flow information is relatively unaffected by 
concomitant antianginal therapy, which markedly reduces the sensitivity of ischemia-
dependent regional wall motion abnormality and does not influence coronary flow reserve, or 
does so only to a limited extent. As a result, CFR can already help in the difficult task of 
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identifying patients with coronary artery disease in accordance with the classic ischemic 
cascade. 
VISUALISATION OF THE CORONARY ARTERIES WITH INVASIVE 
TECHNIQUES 
1. Coronary angiography 
Coronary angiography is the reference standard for coronary artery imaging and provides the 
most reliable information for making treatment decisions about medical therapy, angioplasty, 
or bypass surgery.  
Coronary artery anatomy: The heart is supplied by the left and right coronary arteries, 
which usually originate from the left and right sinuses of Valsalva, respectively. 
Angiographic Lesion Quantification: Under stress conditions, normal coronary artery flow 
can increase three- to fourfold (coronary flow reserve of 3 to 4). With luminal diameter 
reductions of greater than 50% (75% cross-sectional area reduction), the ability to normally 
increase coronary flow reserve may be impaired (i.e., less than 50% diameter narrowing is 
usually hemodynamically insignificant). Greater than 70% diameter stenosis (90% cross-
sectional area) severely limits the ability to increase flow above resting level. A 90% diameter 
stenosis may reduce antegrade blood flow at rest (30). Also important is lesion length, 
whereby a 50% narrowed 10-mm lesion will be less hemodynamically significant than a 50% 
narrowed 30-mm lesion. The capability of coronary angiography to quantify the degree of 
stenosis is limited by the fact that the image is a “lumenogram.” Stenoses can be evaluated 
only by comparison to adjacent reference segments, which are presumed to be disease-free. 
The majority of arteries will have disease in the reference segment, leading to underestimation 
of stenosis severity. In addition, vessel segments adjacent to areas of denser contrast (e.g., an 
overlying branch artery) are prone to perceptual artefact due to the Mach effect (31), a 
consequence of the physiologic process of lateral inhibition. These neuroinhibitory 
interactions in the retina and central nervous system of the observer cause artery segments 
adjacent to the denser overlying artery to appear less dense and simulate stenosis. To enhance 
quantification of vessel size, the absolute diameter of the coronary artery can be compared to 
the size of the diagnostic catheter. This approach to lesion quantification is limited by its 
dependence on visual estimation and suffers from significant operator variability To 
overcome these limitations, digital callipers and quantitative coronary angiography (QCA) 
have been developed (Figure 1.), as have several computer-assisted approaches to quantitative 
angiography (32). 
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Figure 1. QCA measurement of borderline distal LM stenosis.  
 
2. Intravascular ultrasound 
The incremental value of IVUS compared to contrast angiography is due to its tomographic 
perspective and its ability to directly image atheroma and vessel wall (4). Angiography 
depicts cross-sectional anatomy as a planar silhouette of the lumen, whereas direct imaging by 
IVUS allows measurement of atheroma size, distribution, and composition. Although 
angiography remains the principal method to assess the extent of coronary atherosclerosis and 
to guide percutaneous coronary intervention, intravascular ultrasound has become a vital 
adjunctive imaging modality.  
Advantage of intravascular ultrasound: IVUS has several important advantages over 
traditional angiography. First, IVUS allows precise quantitation of disease severity. (33). 
Second, the tomographic orientation enables visualization of the entire circumference of the 
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vessel wall, rather than a two-dimensional silhouette of the lumen (4). Third, IVUS allows 
characterisation of plaque composition, distribution, and length, which has important 
implications for device selection and assessment of results. Finally ultrasound allows the 
cardiologist to assess disease in vessels that are typically difficult to image by conventional 
angiography, including diffusely diseased segments, lesions at bifurcation sites, ostial 
stenosis, and highly eccentric plaques. Although vessel foreshortening and overlapping 
structures often preclude accurate quantitative angiography, IVUS by these factors.  
Advantages of IVUS are the precise quantitative measurements (lumen diameter, reference 
vessel diameter, cross-sectional area, lesion length) and the characterisation of plaque (arterial 
remodelling, plaque stability, plaque distribution, plaque composition, dissection) 
Image interpretation:  
Normal coronary arterial morphology: IVUS often depicts the normal coronary artery as a 
trilaminar structure (34) The innermost layer (at the lumen/wall interface) represents the 
intima. When present, it appears as a delicate, echoreflective (white) band due to acoustic 
reflections from the internal elastic lamina. The media visualised as a distinct echolucent 
(black or dark gray) middle layer, which is bordered by a third, outer echodense media-
adventitia interface. The characteristic trilaminar pattern is not observed in 30-50 % of normal 
coronary arteries; the thin intimal layer reflects ultrasound poorly and often leads to signal 
dropout and a monolayer appearence. (35) Wheather the artery is trilaminar or monolayered, 
the deepest layers of adventitia and peri-adventitial tissue exhibit a characteristic „onionskin” 
pattern. The outer border of the vessel is usually indistinct, primarily because there are no 
acoustic differences between the adventitia and surrounding tissues. Accordingly, total wall 
thickness cannot be measured reliably using ultrasound, except in vessels with a distinct outer 
border (such as saphenous vein bypass grafts).  
Plaque composition: In practice, IVUS defines three broad classes of coronary lesions: soft 
lesions, where echogenicity of the atheroma is less than the adventitia, fibrous lesions, where 
the atheroma is of equal to the adventitia,and calcific or fibrocalcific lesions, where the 
atheroma is mor echodense than the adventitia. Overt calcification is highly likely when 
dense, bright echoes are accompanied by shadowing of the deeper structures. 
Atheroma distribution: Plaque may be described as concentric or eccentric, with or without 
ulceration. Arterial remodelling: Remodelling is defined as a change in vessel area due to 
atherosclerosis. Remodelling can be positive (in which vessel area increases with atheroma 
development) or negative (in which the vessel area decreases). Glagov described an increase 
in arterial size that appeared to accommodate the deposition of atherosclerotic plaque. In 
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lesions with area stenosis <30-50%, the increase in arterial size “overcompensates” for plaque 
deposition, leading to an increase in lumen area. With more advanced lesions (area stenosis 
>40%), the degree of arteria enlargement is less, and luminal diameter becomes progressively 
smaller with disease progression (Glagov). 
Unstable Lesions and Ruptured Plaque: No definitive IVUS features define a plaque as 
vulnerable (36). However, necropsy studies demonstrated that unstable coronary lesions are 
usually lipid-rich with a thin fibrous cap. Accordingly, hypoechoic plaques without a well-
formed fibrous cap are presumed to represent potentially vulnerable atherosclerotic lesions. 
Ruptured plaques have a highly variable appearance by IVUS. In patients studied after an 
acute coronary syndrome, ultrasound imaging may reveal an ulceration, often with remnants 
of the ruptured fibrous cap evident at the edges of the ulcer. A variety of other appearances 
are common, including fissuring or erosion of the plaque surface. 
 
  
Ambiguous Lesions: Angiographically ambiguous lesions may include: 1) intermediate 
lesions of uncertain stenotic severity; 2) aneurysmal lesions; 3) ostial stenoses; 4) disease at 
branching sites; 5) tortuous vessels; 6) left main stem lesions; 7) sites with focal spasm; 8) 
sites with plaque rupture; 9) dissection after coronary angioplasty; 10) intraluminal filling 
defects; 11) angiographically hazy lesions; and 12) lesions with local flow disturbances. 
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Intravascular ultrasound is frequently employed to examine lesions with the above 
characteristics, in some cases providing additional evidence useful in determining whether the 
stenosis is clinically significant (i.e., difficult to assess left main or borderline stenosis with 
continued symptoms). However, it must be emphasized that IVUS does not provide 
physiologic information per stenosis severity.  
Dimensional measurements:  All measurements during IVUS are taken “leading edge to 
edge”. Intimal thikness is defined as the distance form the intima to the external elastic 
membrane (adventitial leading edge). Some investigators prefer to call this the “intima-
media” or “plaque plus media” thickness, because this measurement includes both media and 
atheroma. The rationale for this conversation is that the normal media is frequently indistinct 
because its thickness is only slightly greater than the axial resolution of the imaging system. 
The most common IVUS measurements include the lumen cross-sectional area (Lcsa), 
external elastic membrane cross-sectional area (EEMcsa), maximum intimal thickness (IT-
max), minimum intimal thickness (ITmin), vessel diameter and minimum lumen diameter 
(MLD). Common calculations include the percent plaque burden (%PB) or the percent cross-
sectional narrowing (%CSN), the intimal index, the eccentricity index and diameter stenosis 
(DS) (37).  
Diagnostic and interventional applications of IVUS: Although coronary angiography is 
considered the reference standard for coronary artery imaging, it detects only arterial disease 
that impinges on the luminal column of contrast medium. It has limited ability to detect 
plaque content or the disease process itself. In contrast, intravascular ultrasonography (IVUS) 
provides tomographic assessment analogous to histologic cross-sections and provides 
information about plaque morphology, vessel wall structure, and luminal and vessel area. 
IVUS offers the following advantages over angiography: 
• Clarification of angiographically equivocal or intermediate lesions. This is especially helpful 
with left main lesions, which can be difficult to quantitate with angiography. 
• Assessment of coronary stenoses before and after catheter-based coronary interventions. 
IVUS has proven useful in determining true vessel size prior to stent implantation and 
appropriate stent strut apposition after stent implantation. 
• In cardiac transplant recipients, coronary artery disease is best studied by IVUS because of 
the diffuse nature of atherosclerosis that develops after transplantation 
 
TRANSRADIAL ACCESS FOR CORONARY AND PERIPERAL INTERVENTIONS 
1. Transradial coronary angioplasty in STEMI 
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In the treatment of patients with unstable angina and acute myocardial infarction PCI plays a 
crucial role. Aggressive antithrombotic therapy is a cornerstone of contemporary PCI in order 
to limit the occurrence of thrombotic complications during and after the procedure. However, 
access site complications occur more frequently using this aggressive adjunctive 
pharmacological therapy. The transradial way for coronary angioplasty and stenting was first 
published by Kiemeneij and Laarman (38). The rationale for the TR approach has been to 
attempt to reduce the incidence of bleeding complications and the vascular access site and the 
necessity for prolonged bed rest. Being able to avoid local complications of TR coronary 
angioplasty is mainly determined by the favourable anatomic relations of the radial artery to 
its surrounding structures. A number of studies have confirmed its applicability and potential 
advantages over the TF approach in elective and acute procedures (39-42). 
 
2. Transradial angioplasty in carotid artery stenting 
Stenting of the internal carotid artery has gained wide acceptance in the treatment of occlusive 
disease of the extracranial cerebral arteries (43,44). The results are constantly improving 
because of the introduction of new embolic protection devices and small caliber catheter and 
stenting systems. The conventional way to access the common carotid artery during 
endovascular interventions is through the femoral artery; however, this approach is not always 
possible because of vessel pathology or aberrant anatomy in the iliofemoral arteries and the 
aortic arch. A transbrachial or a direct transcervical approach can be employed as an 
alternative when femoral access is not possible. We have performed carotid artery stenting 
(CAS) in our hospital since 2001. We initially utilized the transcervical approach if femoral 
access was not possible. We decided to start using transradial access (TRA) for carotid 
stenting following the performance of several successful cerebral angiographies via radial 
artery access. 
 
3. Transradial angioplasty in renal artery stenosis 
Fibromuscular dysplasia, which affects mostly young females, is the underlying disease in 10 
percent of all renal artery (RA) stenosis. The remaining 90 percent are caused by 
atherosclerotic narrowing of the renal artery. The incidence of RA stenosis increases with age 
and is higher among those with diabetes and patients with known aortoiliac occlusive disease, 
coronary artery disease, and hypertension (45). Percutaneous transluminal intervention is a 
balloon dilation method, used either alone or with stent implantation. The open surgical 
procedure may be an anatomical (aortorenal) or an extra-anatomical bypass (bypass from the 
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celiac or mesenteric artery), a procedure that has recently been preferred at some centres. 
Percutaneous transluminal intervention is usually performed through the femoral or brachial 
artery. There are only a few reports on RA stenting using the radial artery as an access site 
(46). 
 
OPEN ISSUES IN THE ELUSIVE CLINICAL QUEST OF CORONARY 
ANGIOGRAPHY AND TRANSFEMORAL INTERVENTION 
 
Pitfalls of Coronary Angiography: Most of the pitfalls in coronary angiography involve 
errors of omission whereby stenoses or anomalies are not appreciated. The most common 
angiographic pitfalls are: Unrecognized LMCA stenosis. The LMCA should be viewed in 
several projections with the vessel unobscured by the spine. Catheter pressure damping (a 
result of “wedging” into a stenosed vessel causing a damped waveform) and the absence of 
contrast reflux into the aorta suggest the presence of ostial LMCA disease. Several factors 
make adequate assessment of ostial LM stenosis challenging; they include the inherent 
difficulty of assessing aorto-ostial disease, vulnerability to catheter- induced vasospasm (see 
below), the high degree of interobserver variability of LMCA stenosis severity, and the 
prognostic significance of over- or underestimating LMCA lesion severity. Too few 
projections. Eccentric lesions and those obscured by overlap will go unnoticed unless 
additional projections are made. Detection of eccentric stenosis requires that the short axis of 
the stenotic lumen is projected. Inadequate opacification. Inadequate opacification can result 
in streaming and give the impression of ostial stenosis, missing side branches, thrombus, and 
stenosis over- or under-estimation. Properly sized catheters and injection rates avoid this 
problem. Aorto-ostial lesions. If an aorto-ostial lesion is suspected by partial 
ventricularization or pressure damping, injecting during withdrawal of the catheter from the 
ostium may be useful. Failure to recognize occlusions. Occlusions at branch origins tend to 
escape detection and may be recognized only by late filling of the distal segment by collateral 
circulation. Catheter tip-induced spasm. Catheter tip-induced spasm can occur at or within 1 
cm of the catheter tip. It is caused by mechanical irritation and reflex contraction of the artery. 
Intracoronary or sublingual nitroglycerin should be given before the injection is repeated. 
 
Transfemoral interventions in acute coronary syndromes:  
Aggressive antithrombotic therapy is very important in order to limit the occurrence of 
thrombotic complications during and after the procedure. Nevertheless, during transfemoral 
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PCI this aggressive antithrombotic treatment is associated with a high risk of access site 
complications. Kiemenej et al. compare the results of transradial approach with the brachial 
and femoral approaches in randomized study (ACCESS study) (39). They found that although 
the vascular access site complication rate was not significantly lower after the transradial 
approach (0%) than  the transfemoral (2%) or brachial approaches (2%) (p =0.05), however in 
patients treated with the platelet GP IIb/IIIa inhibitor the missing major access site bleeding 
complications in the radial group, proved to be significantly less to the five occurrence (7%) 
in the femoral group (p =0.04) (4). Despite the improvement of access site management after 
transfemoral intervention with the advent of vascular closure devices, bleeding complication 
remains a great challenge (47).  
 
Transfemoral interventions for carotid artery stenting:  
Stenting of the internal carotid artery has gained wide acceptance in the treatment of occlusive 
disease of the extracranial cerebral arteries (48). The results are constantly improving because 
of the introduction of new embolic protection devices and small caliber catheter and stenting 
systems. The conventional way to access the common carotid artery during endovascular 
interventions is through the femoral artery; however, this approach is not always possible 
because of vessel pathology or aberrant anatomy in the iliofemoral arteries and the aortic arch. 
Specifically, for cases performed viathe femoral route, potential complications include the 
formation of a hematoma, frank hemorrhage, retroperitoneal bleeding, pseudoaneurysm or 
arteriovenous fistula formation, or even the loss of peripheral pulses with associated leg 
ischemia (49). The most common underlying cause for local complications remains the 
anatomically incorrect arteriotomy site (too high above the inguinal ligament, or too low in 
one of the femoral artery branches) but there are also other patient-related risk factors, such as 
female sex, advanced age, a high systolic blood pressure, and even the inappropriate use of 
closure devices. In addition, the introduction of more potent antiplatelet and anticoagulant 
regimens (low molecular weight heparins, glycoprotein (GP) IIb/IIIa inhibitors,high doses of 
clopidogrel, direct thrombin inhibitors,etc.) has contributed to significant reductions in the 
ischemic complications of PCI, at the expense, however, of persistently high local 
complication rates (with the exception of the recently introduced direct thrombin inhibitors, 
specifically bivalirudin) (50-52). Specifically,while a recent meta-analysis demonstrated a 
90% reduction in emergency coronary artery bypass operations in patients undergoing PCI 
over a ten-year period,7 in another recent meta-analysis including almost 13,898 PCIs the 
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rates of local complications, even in contemporary practice, still remain high with an overall 
incidence of 3.4% (53). In recent years, a number of closure device systems have been 
introduced with the purpose of reducing immobilization times post PCI and the hope of 
reducing the frequency of local complications. Large clinical trials have indeed demonstrated 
the patients’ preference for the use of these closure devices compared to the long bed rest 
associated with the more traditional manual compression. However, in these studies 
reductions in local complications associated with the use of these devices were not 
demonstrated.  
 
THE PRIMARY GOALS OF THE DISSERTATION 
The main objective of the present thesis was to examine the role of transthoracic and 
transoesophageal echocardiography in the detection of proximal epicardial stenosis and to 
determine the applicability of transradial artery access in percutaneous coronary, carotid and 
renal artery stenting.  
 To achieve this, the followings have been analyzed: 
1. Comparative study between IVUS, quantitative coronary angiography and 
transthroracal Doppler echocardiography and an additional case report in a patient 
with borderline left main stenosis.   
2. Evaluation of borderline stenosis severity in the proximal section of the LAD with , 
quantitative coronary angiography, intravascular ultrasound and CFR measured by 
transesophageal echo.  
3.  The purpose of the study was to evaluate the outcome, device consumption and the 
rate of vascular complications during transradial angioplasty in ST segment elevation 
myocardial infarction compared to the transfemoral access.  
4. We report our early experience with transradial access for carotide artery stenting and 
in a case report for renal artery stenting.  
 
METHODS 
Coronary angiography and quantitative angiography: All patients underwent standard 
angiography, at the beginning of which intracoronary nitroglycerine (0.2 mg) was 
administered to achieve maximum vasodilatation. Measurements were then taken from two 
orthogonal views. Data were recorded on CD-ROM to allow offline assessment. The edge-
detection technique developed by Reiber, et al. (CMS, Medis) was used for QCA assessment 
An empty guiding catheter was used for calibration, and diameter stenosis (%) was 
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determined using a computer quantitative analysis (General Electrics) program. Stenosis was 
considered significant if QCA showed diameter stenosis greater than 70%.  
 
Intravascular ultrasound: IVUS and coronary angiography were performed at one sitting 
using an Atlantis Plus 40 MHz catheter (Boston Scientific). After guided catheter cannulation 
of the LMCA, a 0.014” guidewire was introduced into the distal LAD and the IVUS catheter 
was placed into the distal position. The IVUS catheter was withdrawn at 0.25 mm/s by 
automated pullback, while IVUS measurements were recorded on super VHS. Quantitative 
measurements were taken according to the IVUS standards of the American Society of 
Cardiology. In each case we measured minimum lumen diameter (MLD, mm), minimum 
lumen cross-sectional area (LCSA, mm2), and external elastic membrane cross-sectional area 
(EEM-CSA, mm2). A physician, who was experienced in IVUS, but independent of the study, 
measured vessel diameter at its narrowest region. LAD stenosis was considered significant if 
LCSA was smaller than 4 mm2, while values less than 7.5 mm2 indicated significant left main 
stenosis (37).  
 
 
 
 
 
 
 
 
 
 
 
 
 
3.  
 
Transthoracic echocardiography for LM assessment: TTDE studies were performed with 
a Vivid 8 ultrasound equipment (General Electric, New York, USA)  using a 3.5 MHz 
transducer with harmonic imaging. All TTDE studies were carried out by an experienced 
sonographer blinded to the angiographic and IVUS findings. B-mode image was used to 
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identify the LM and pulsatile Doppler to measure the flow velocity in diastole. Imaging plane 
was oriented in parallel with short-axis view of the aortic root slightly above the aortic valve. 
Sample images were stored digitally for subsequent analysis analysis. 
 
Transoesophageal echocardiography: TEE was performed one day before IVUS in each 
case, using a Toshiba Power vision 8000 system with a high frequency (5-12 MHz) 
transducer. Patients received local lidocaine and IV midazolam. After LAD visualization and 
flow visualization with colour Doppler, flow velocity in the proximal LAD was measured 
using pulsatile Doppler first at rest, proximal to the lesion, then at peak dipyridamole effect (6 
min after initial dipyridamole infusion, 0.56 mg in 4 min). Blood pressure and heart rate were 
monitored during the examination. The position of the transducer remained unchanged during 
dipyridamole infusion in order to maintain identical positions when measuring the resting and 
hyperaemic flow. CFR value was calculated from the ratio of the peak and resting diastolic 
velocities; values lower than two were considered pathologic. Diaphylline was administered 
at the end of the study to antagonize the effects of dipyridamole. Each measurement was 
recorded on super VHS, and digital pictures were stored for subsequent offline analysis.  
 
Transradial angioplasty in acute coronary syndromes 
Anticoagulant regimen. All patients were treated before the procedure with aspirin and 
clopidogrel (300 mg oral loading dose, then 75 mg PO for 6 months). A bolus of 
intracoronary Na-heparine (5000 U) was administered after sheath placement. Tirofiban – 
(Aggrastat) (180 mcg/kg iv. bolus plus 2.0 mcg/kg/min iv. infusion) or eptifibatide (Integrilin) 
(10 mcg/kg iv. bolus plus 0.15 mcg/kg/min iv. infusion) was administered before or during 
the procedure. Vascular access and procedure (Table 1). For the radial approach, an 
ischaemic Allen test contraindicated the procedure. After local anaesthesia (2% Xylocaine) 
modified Seldinger method was used for cannulating the radial artery with a 21-gauge needle, 
and a 0.021 inch straight wire was advanced in the radial artery. For cannulation of the radial 
artery a 6F dedicated transradial sheath (10 cm) was used (Cordis, Transradial Kit). 
Intraarterial vasodilators (2,5 mg verapamil, 5000 IU heparin sodium, 250 mcg 
nitroglycerine) were injected directly in the radial artery through the sheath. After the 
procedure the sheath was removed immediately and haemostasis was achieved with a 
tourniquet for 6 hours. We did not apply a dedicated haemostatic device. Despite radial artery 
access the patient was immobilised in the ICU for 24 for hours.  For the femoral approach 
after local anaesthesia the femoral artery was punctured with a 19- gauge needle through 
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which a J wire was advanced in the femoral artery. A 6F sheath was introduced in all cases, 
but in case of a true bifurcational lesion it was replaced for 7F allowing for use of 7F guiding 
catheter for “kissing technique”. In transradial cases 6F guiding catheter was used routinely 
for „kissing technique” due to the size of the radial artery. The arterial access sheaths were 
removed 4 hours after the procedure, and after mechanic compression a pressure bandage was 
used for 12 hours.  
 
 
 
 
 
 
 
 
Angiographic analysis / angioplasty procedure. Angioplasty was performed according to 
the standard clinical practice. According to the guidelines, bare metal stents were used, we 
avoided application of drug-eluting stents. All angiograms were evaluated after ic. 
administration of nitrates. The vessels and the lesions were analysed by using a computerized 
quantitative analysis system (Siemens Hicor). Measurements were obtained with digital 
calliper method.   
 
Transradial access for carotid artery stenting: Prior to TRA, every patient has an Allen’s 
test performed. The test is considered as normal (negative Allen’s test) if the palm colour 
returns to normal within 10 seconds. The right arm of the patient is positioned on an arm 
holder, abducted 45 °. The wrist is hyper extended over a gel pad and the arm is prepped and 
draped to the axilla. After access is gained, the arm can be left in an abducted position for left-
handed operators, or, placed parallel to the body to facilitate catheter manipulations for right-
handed operators. Local anaesthesia is infiltrated along the distal radial pulse. The artery is 
Transradial Transfemoral
Drugs Pre-procedural ·  Aspirin
· Clopidogrel
·  Aspirin
·  Clopidogrel
Peri-procedural NaHeparin 50 U/kg NaHeparin 100 U/kg
Antispasmolitic cocktail ·  2,5 mg Verapamil
· 200 µg NTG
· 5000 IU of Heparin
Puncture ·  19 gauge needle
· 0.022” straight wire or
· 0.035” J wire with straight tip
· 6-7 F short or long sheath
· Modified Seldinger technique
·  19 gauge needle
·  0.035” J wire
·  Modified Seldinger technique
Cannulation of the coronary arteries LM: JL, EBU, AL
RCA: JR, ART, SCR, MP
LM: JL, EBU, AL
RCA: JR, ART, SCR
Guidewire Depends on the lesion Depends on the lesion
Sheath removal Immediately after the procedure 4 hours after the procedure
(ACT <200)
Pressure bandage Elastic torniquet for 6 hours (not occlusive 
bandage !)
Elastic torniquet for 6-12 hours
Mobilisation Very early ( 6-12 h) 24 h after the procedure
Table 1 Technical descriptions of procedures
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punctured with a Check-Flo™ micro puncture radial artery access-set (Cook®) and a 5 Fr short 
sheath is introduced. Systemic unfractionated heparin is administered intravenously to achieve 
an activated clotting time (ACT) > 250 s, and a “spasmolytic cocktail” (200µg Nitro-
glycerine, 2.5mg Verapamil) is given intra-arterially through the side arm of the sheath in 
order to prevent spasm secondary to vessel manipulation. It is necessary to use multiple views 
to optimize visualization of the carotid anatomy. We use variable projections and patient head 
positions to obtain the widest angle at the carotid origin. The right or left common carotid 
artery (CCA) is cannulated with an appropriately shaped diagnostic catheter and hydrophilic 
guide wire. We prefer to use the Internal Mammary Artery (IMA), Simmons 1 or Bernstein 
catheter configurations for cannulation of the right CCA (all selective catheters are Imager TM 
II from Boston Scientific). For cannulation of the left CCA in patients with bovine arch 
anatomy, we use the Bernstein or JB1 catheter (Imager TM II from Boston Scientific) 
configurations. For cannulation of the left CCA in patients with standard (normal) aortic arch 
anatomy we prefer to use the Simmons 2 (Imager TM II) selective diagnostic catheter. The 
catheter is then advanced just proximal to the carotid bifurcation and an Amplatz Super Stiff 
TM (Boston Scientific) wire is positioned in the external carotid artery (ECA) to provide 
support for the subsequent sheath exchange. In cases of angulated, tortuous aortic branch 
vessels, where access with the Super Stiff TM wire is unable to be maintained, we resort to use 
of a “telescope” technique. For the “telescope” technique, a hydrophilic 0.035” Terumo® 
Glidewire (260 cm) is utilized to advance a diagnostic angiography catheter into the distal 
CCA. The selected guiding sheath is then advanced over the catheter – wire combination just 
proximal to the carotid bulb. We use a 6 Fr or 7 Fr, 90cm hydrophilic guide sheath; either a 
Terumo® Destination TM carotid guiding sheath or a Shuttle SL Flexor TM with a Tuohy-Borst 
side-arm  from Cook®. The size of the guide sheath must accommodate both the carotid stent 
platform (which is usually 5 Fr or 6 Fr) and allow for continuous flushing with heparinised 
saline, as well as adequate contrast administration during the procedure. We have found that 
using matched French sizes for the guide sheath and the carotid stent, limits our ability to 
perform adequate flushing and contrast injections, thus we oversize the guide sheath by one 
French size in relation to the carotid stent system that is utilized. Road map angiography is 
performed to confirm that the degree of stenosis is 60% or greater. The degree of 
angiographic carotid artery stenosis is calculated according to NASCET criteria (48). 
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid 
stenosis. The embolic protection device is deployed in the usual fashion and after 
administration of 1 mg intravenous Atropine, predilatation of the carotid stenosis with a small 
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diameter (3.0 or 3.5 mm)  angioplasty balloon (Ultrasoft™ SV, Boston Scientific) is 
performed if necessary to facilitate positioning of the carotid stent. The carotid stent is 
deployed and post-dilated with a 5.0 mm diameter angioplasty balloon (Ultrasoft™ SV, 
Boston Scientific) if necessary. We prefer to use the Zilver Stent (Zilver® 518, Cook®)  
because of the very low profile (5 Fr), but we have also used 6 Fr systems such as the Carotid 
Wallstent™ Monorail™ (Boston Scientific) or Precise Stent (Precise™ RX, Cordis Corporation, 
Miami, USA). After completion angiography, the protection system and the sheath are 
removed without reversal of anticoagulation. The puncture site is compressed by hand for 5 
minutes. We then use a 5-mL syringe with both ends cut off that has been wrapped with gauze 
to maintain pressure on the radial artery puncture site for six hours. The syringe is positioned 
longitudinally along the course of the distal radial artery and held in place with a non-
circumferential elastic tape. The patient is moved to the postoperative care unit for 2 hours 
and then sent to the ward. The patient’s neurologic status is evaluated by the interventionalist 
at the completion of the procedure, at removal of the bandage, prior to discharge and at 30-
day follow-up. If a neurological deficit is observed, then a neurologist is consulted to evaluate 
the patient. Patients are allowed to ambulate and eat without restrictions. They are kept for 
observation for one night in the hospital and discharged home on the first postoperative day. 
The radial pulse is palpated and the adequacy of the hand’s blood supply is evaluated 
clinically when the dressing is removed, at the time of discharge and at 30-day follow-up. 
 
Transradial access for renal artery angioplasty: After successful cannulation of the radial 
artery, the renal artery was cannulated with a 90-cm 7F Mach1 MP catheter then the distal 
vessel with a 0.014-inch extra support guide wire (Boston Scientific; Natick, MA) (Figure 1). 
Following pre-dilation with a 3×20-mm Phantom balloon (PanMedical, Gloucestershire, 
United Kingdom), a 6x18- mm Express SD stent (Boston Scientific; Natick, MA) was 
implanted with 10 atm. The proximal 1–2 mm of the stent was left to protrude into the aorta. 
Finally, a balloon postdilation of the stent at the aortic end was performed. Control 
angiography showed no residual narrowing.  
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STUDY PROTOCOLS 
1. COMPARISON BETWEEN TRANSTHORACAL, INTRAVASCULAR 
ULTRASOUND AND CORONARY ANGIOGRAPHY: Consecutive patients with 
angiographically documented borderline LM stenosis (30 to50%)  (n =26, mean age: 64±8 
years, 19 males) were enrolled in the present study. Following coronary angiography, LM has 
been evaluated by IVUS and TTDE in all patients. Exclusion criteria were hemodynamic 
instability, acute myocardial infarction, hypertrophic cardiomyopathy, severe obesity (BMI 
>35 kg/m2), known congenital heart disease. Patients were informed about the study itself, its 
proceedings, and possible adverse events. The study satisfied with Declaration of Helsinki 
and was approved by ethical committee of University of Szeged. 
 
2. COMPARISON BETWEEN TEE-CFR, INTRAVASCULAR ULTRASOUND AND 
CORONARY ANGIOGRAPHY: The only inclusion criterion was that the patient had 
coronarography-confirmed borderline lesion of the proximal LAD. Following 
coronarography, the LAD was examined by IVUS and TEE-CFR was performed. Exclusion 
criteria were severe left ventricular hypertrophy (because of the CFR-decreasing effect of 
hypertrophy), myocardial infarction within one month, significant left main and ostial LAD 
stenosis confirmed by angiography, and contraindication to dipyridamole (second or third 
degree AV block, sinus node dysfunction, severe chronic obstructive pulmonary disease, 
bronchospasm). Nine patients were excluded from the study due to significant left main or 
ostial LAD lesions because these types of lesions could limit TEE-CFR assessment. Patients 
refrained from taking food or drink containing theophylline or xanthine 24 hours before TEE, 
and they were not given any coronary drugs. Patients were informed about the study itself, its 
proceedings, and possible adverse events. The study satisfied the Helsinki Declaration and it 
was approved by the ethical committee of the University of Szeged. 
 
3. TRANSRADIAL ANGIOPLASTY IN ACUTE CORONARY SYNDROMES: The 
clinical and angiographic data of 582 consecutive STEMI patients undergoing primary or 
rescue PCI were reviewed retrospectively, and evaluated. All of the patients with STEMI (n 
=582) was labelled into transradial (TR, n =167) or transfemoral (TF, n =415) group. The 
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transradial interventions were performed by experienced (>300 TR procedures previous to the 
study period) operators. Several parameters were applied to evaluate the potential advantages 
or drawbacks of TR access: access site cross over, rate of access site complications, major 
adverse cardiac events (MACE) at 1-month and consumption of angioplasty equipment. 
Selection of the access site was made by the operator’s preference. The patients with rescue 
PCI and cardiogenic shock were excluded from the study. Criteria for the diagnosis of STEMI 
were chest pain lasting at least 30 minutes not responsive for nitrates and ST segment 
elevation on the electrocardiogram of at least 0.2 mV in 2 or more contiguous precordial leads 
or 0.1 mV in 2 or more extremity leads or non-diagnostic electrocardiogram (left bundle-
branch block, ST-segment depression or T wave inversion). Rescue PCI was defined as PCI 
within 12 hours after failed fibrinolysis for patients with continuing or recurrent myocardial 
ischemia. The clinical criteria of cardiogenic shock were hypotension (a systolic blood 
pressure of <90 mm Hg for at least 30 minutes or the need for supportive measures to 
maintain a systolic blood pressure of 90 mm Hg) and end-organ hypoperfusion (cool 
extremities or a urine output of <30 ml per hour, and a heart rate of 60 beats per minute).  
Endpoints and definitions. The following parameters were applied to evaluate the potential 
advantages of TR access:  
-  Primary endpoint: MACE, rate of access site complications  
- Secondary endpoints: angiographic outcome of the PCI, and consumption of angioplasty 
equipment and cross over to another puncture site.  
A successful angioplasty met three criteria: no more than 50 percent post-intervention 
stenosis, improvement of at least 20 percent in the degree of stenosis, and a flow of 
Thrombolysis in Myocardial Infarction (TIMI) grade II or III. Access site bleeding was 
defined as major if associated with haemoglobin loss of at least 2 mmol/l, administrations of 
blood transfusions, vascular repair and prolonged hospitalisation, and minor if bleeding at 
vascular access site only resulted in hematoma formation and did not require specific therapy. 
Major adverse cardiac events (MACE) were assessed as the composite of death, nonfatal 
acute myocardial infarction, and repeated revascularization of the target vessel by PCI or 
coronary artery bypass graft operation) during the hospital stay and at 30-day. 
4. TRANSRADIAL ANGIOPLASTY IN CAROTIDE ARTERY STENTING:  
There were 46 patients treated with carotid stents during the study period (March 2006 – 
December 2006). This study is a retrospective review of twenty patients who had CAS 
performed using TRA. The transradial approach was utilized only by the first (LP) and senior 
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authors (RK) in the institution. All patients underwent carotid stenting because they were 
considered high risk for open carotid endarterectomy. Grade of carotid stenosis was 
determined by use of preoperative duplex ultrasonography, computer tomographic 
angiography (CTA) or magnetic resonance angiography (MRA), but degree of stenosis was 
always verified by intra-operative angiography. All carotid stenting procedures were 
performed in the operating room using a portable C-arm (OEC 9800 Plus, General Electric). 
All patients provided informed consent prior to performance of any intervention. The major 
complications (within 30 days) evaluated were perioperative myocardial infarction, stroke or 
TIAs and death. Technical success, peripheral nerve injury, access site hematoma, radial 
artery occlusion or digital ischemia, as well as, pain and early ambulation were also evaluated. 
 
RESULTS 
1. COMPARISON BETWEEN TTE, INTRAVASCULAR ULTRASOUND AND 
CORONARY ANGIOGRAPHY:  
Clinical and demographic patient data are demonstrated in Table 1.  All study patients 
underwent positive Treadmill test or had ST segment depression under chest pain. Eight 
patients were presented with troponin negative acute coronary syndrome (33%). 
Table 1. Clinical characteristics of study population 
Parameters n (%) 
Age (year) 64 ± 8 
Male gender (%) 18 (75) 
Systemic hypertension (%) 16 (67) 
Hypercholesterolemia (%) 14 (58) 
Current smoker (%) 8 (33) 
Diabetes mellitus (%) 
Canadian angina classification: 
- I.                                                 0 (0)                          
- II.                                                5 (21)                         
- III.                                               11 (46) 
- IV.                                               8 (33) 
7 (29) 
 
Previous myocardial infarction (%) 9 (37.5) 
Previous coronary bypass surgery (%)  0 (0) 
 
Transthoracic echocardiography:  Interpretable Doppler signal could be obtained in 24 
patients (88 % feasibility). Mean resting peak diastolic Doppler velocity was 140 ± 58.5 cm/s 
in the LM. 
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• QCA 
– MLD (mm)    2.6 ± 0.7 
– Diameter stenosis (%)   36.5 ± 9.6  
– Area stenosis (%)   58.15 ± 12.25 
– Reference diameter (mm)  4.10 ± 1.10 
– Lesion length (mm)   7.2 ± 3.2 
• IVUS 
– Quantitative analysis 
• LM MLA site 
– MLA (mm²)  7.1 ± 2.7 
– MLD (mm)  2.75 ± 0.7 
– Plaque burden (%) 52.8 ± 21.8 
• TTDE 
Quantitative coronary angiography: Mean LM diameter stenosis was 36.5 ± 9.6 %, area 
stenosis was 58.15±12.25 %, MLD was 2.6 ± 0.7 mm and lesion length was 7.2 ± 3.2 mm. 
Intravascular ultrasound: Clear IVUS images were obtained in all cases and no 
complications occurred during the recordings. IVUS revealed significant LM stenosis in 17 
patients (71%) Fourteen patients with significant LM stenosis underwent percutaneous 
coronary intervention (PCI), 3 patients were referred for bypass surgery (12.5%), while 7 
patients were considered having haemodynamically non-significant lesions, and therefore 
were recommended for further medical treatment and follow up (29%). Decision was made by 
intravascular ultrasound. Mean MLA in the LM was 7.1 ± 2.7  mm2, mean MLD was 2.75 ± 
0.7 mm and mean plaque burden was 52.8 ± 21.8 %.    
Table 2. Quantitative coronary angiography, IVUS and TTDE findings 
 
 
 
 
 
 
 
 
 
 
 
 
Correlations between angiographic, IVUS and echocardiographic parameters: There was 
no significant correlation between TTDE and QCA (r= 0.19, p=ns, figure 1.). TTDE measured 
PDV correlated significantly with IVUS-derived MLA (r= -0.46, p<0.05, figure 2.) and 
plaque burden (r=0.51, p<0.05, figure 3.). According to the ROC analysis the best cut off for 
PDV was 112 cm/s 
(sensitivity, 92.%; 
specificity, 62%) (figure 4.).  
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Figure 1. Comparison of peak diastolic velocity (TTDE) and diameter stenosis (QCA) show 
no significant correlation 
(R=0.19, p= ns).  
 
Figure 2. Comparison of 
peak diastolic velocity 
(TTDE) and minimum 
lumea area (IVUS) show 
significant correlation (R= -
0.46, p <0.05). 
 
 
 
 
 
 
Figure 3. Comparison of 
peak diastolic velocity 
(TTDE) and plaque burden 
(IVUS) show significant 
correlation (R= 0.51, p 
<0.05). 
 
 
 
 
 
Figure 4. ROC analysis of 
peak diastolic velocity 
(TTDE) and minimum 
lumen area (IVUS) 
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2. COMPARISON BETWEEN TEE-CFR, INTRAVASCULAR ULTRASOUND AND 
CORONARY ANGIOGRAPHY:  
Clinical and echocardiographic patient data are listed in Table 1. We performed percutaneous 
coronary intervention (PCI) for all patients with significant LAD stenosis revealed by IVUS 
(n = 25); no major cardiac events occurred.  
 
Transesophageal echocardiography: Proper Doppler signal was obtained for all examined 
patients (n = 42, 100%). CFR assessments were performed without complications in all cases. 
Mean resting Doppler velocity was 54.79 ± 21.44 cm/s in the proximal LAD, and it increased 
to 94.56 ± 25.86 cm/s (p < 0.05) after dipyridamole infusion. The mean CFR was 1.92 ± 0.42. 
CFR remained lower than 2 in 19 cases; these cases were considered significantly 
pathological. 
Quantitative coronarography: The average diameter stenosis in our patients was 37.92 ± 
10.81%.  
Intravascular ultrasound: Clear IVUS pictures were obtained in each case and no 
complications occurred during recording. IVUS revealed significant left main or ostial LAD 
stenosis in nine patients; these patients were excluded from the study. The remaining patients 
had an average minimum lumen diameter of 1.97 ± 0.42 mm and an average cross-sectional 
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area of 3.66 ± 1.39 mm2. LAD stenosis was considered significant if LCSA was smaller than 
4 mm2 (37), while stenosis less than 7.5 mm2 indicated significant LM stenosis (55,56).  
Correlation analysis:  
 
 
 
 
 
 
 
 
 
 
QCA diameter stenosis versus IVUS-LCSA: We analysed the correlation between diameter 
stenosis measured after coronarography and the IVUS-defined lumen cross-sectional area 
using regression analysis and found no significant relationship (r = 0.157, p = ns; Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
QCA diameter stenosis versus TEE-CFR: No significant correlation was found between the 
diameter stenosis and TEE-CFR using linear regression analysis (r = 0.115, p = ns; Figure 2). 
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IVUS-LCSA versus TEE-
CFR: Linear regression 
analysis showed a 
significant correlation 
between the IVUS-defined 
LCSA and the value of 
TEE-CFR (r = 0.622, p < 
0.05; Figure3) 
 
3. TRANSRADIAL ANGIOPLASTY IN ACUTE CORONARY SYNDROMES: 
Baseline demographic and clinical characteristics of study population are shown in Table 1. 
Most of the demographic data did not differ between the two groups, the only exception 
proved to be the incidence of peripheral obliterative disease, which was significantly higher in 
the transradial group (26% vs 9%, p<0.05). Previous CABG was performed in 12 patients 
(17%) in TR group and in 17 patients (8%) in TF group (p =0.02). Previous PCI had been 
performed in 12 patients (17%) in TR group and in 25 patients (11%) in TF group (p =ns). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vascular access (see Table 2): From TR group 156 interventions were performed from the 
right (93%) and 11 (7%) procedures from the left radial artery. The preferred site of TR 
access in our cathlab is the right one, the indication of left radial access was a small diameter 
Table 1. Baseline clinical characteristics of the study patients
Radial group 
(n =167)
Femoral group 
(n =372)
Demographic data Age (years) 62 ± 9 64 ± 8
Male (%) 120 (72) 273 (74)
Hypertension (%) 92 (61) 219 (59)
Dyslipidaemia (%) 59 (35) 122 (33)
Smokers (%) 35 (20) 46 (13)
Diabetes mellitus (%) 43 (25) 
(IDDM: 3 and 
NIDDM: 40)
66 (18)
(IDDM: 11 and NIDDM: 55 )
Severe obesity (%) 24 (14) 31 (8) *
Peripheral obliterative 
disease (%)
27 (16) 33 (9) *
Cardiac history Previous MI (%) 19 ( 28) 49 (13)
Previous PTCA (%) 10 (6) 21 (6)
Previous CABG (%) 4 (2) 10 (3)
GP IIb/IIIa blocking
agents
Eptifibatide or 
Tirofoban (%)
45 (27) 110 (30)
*p <0.05 vs radial group
CFR
1 ,2 1,4 1,6 1,8 2 ,0 2 ,2 2,4 2,6 2 ,8
IVUS (LCSA m
m
2 )
1
1 0
R =0 .62 2
p<0 . 05
F igure 3. : C omparis on of corona ry flow res erve by TEE a nd
minimum lume n a rea by IVU S
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right radial artery in 7 patients (63%) and a negative Allen test in 4 patients (36%). From the 
femoral group 43 patients (11%) were excluded due to cardiogenic shock and rescue PCI. The 
TF interventions were performed in 357 patients (96%) from right femoral access and in 15 
patients (4%) from left femoral access. In the TR group the cross over rate to femoral artery 
was 8 (5%). The of cross over was a severe radial artery spasm in 2 patients, brachial artery 
tortuosity in 5, and an inadequate guiding catheter back up in 1 case. In the TF group the 
procedure was finished via radial artery in 3 patients (1%) due to severe iliac artery tortuosity. 
The cross over rate proved to be significantly more frequent from the radial than from the 
femoral artery (p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Coronary angioplasty success: The procedure was successful in all patients in TR group 
(100%) and in 370 patients (99%) in TF group.  
Consumption of equipments: The consumption of guiding catheters, guide wires, balloon 
catheters and coronary stents proved to be the same for the two groups.  
Complications (see Table 3): The MACE rate was 7 (4%) in TR group and 41 (11%) in TF 
group (p <0.05). The MACE-rate at 1-month was found to be 11% in the TF group and 4% in 
the TR group (p <0.05). In the TR group the myocardial infarction occurred due to a side 
branch occlusion in 1 case and due to stent thrombosis in another case. In the TF group Re-
PCI was due to stent-thrombosis 5 case and acute myocardial infarcion was due to side branch 
occlusion. The cause of death was cardiogenic shock in all cases due to no-reflow 
phenomenon. 
Table 2. Angiographic and clinical characteristics
Radial group
(n =167)
Femoral group
(n =372)
Crossover to other access site (%) 8 (5) 3 (1) 
Access Right (%) 156 (94) 357 (96)
Left (%) 11 (7) 15 (4)
Guide catheter / procedure 203 (1.22) 431 (1.16)
Stent used / procedure 1.12 1.14
GP IIb/IIIa inhibitors (%) 45 (27) 110 (30)
Distal protection device (%) 7 (4) 0 (0)
Thrombus aspiration (%) 15 (9) 54 (14)
Successfull procedure (%) 167 (100) 370 (99)
Vascular closure device (%) 0 (0) 20 (5) *
*p <0.05 vs radial group
20
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Rate of access site complications: GP IIb/IIIa receptor blocking agent was used in 45 
patients (27%) after TR interventions and in 110 patients (30%) after TF interventions (p 
=ns). Major entry site complications were encountered in 19 patients (5%) (2 false aneurysm 
requiring vascular repair, 17 haematomas (requiring blood transfusion in 9 cases and 
prolonged hospitalisation in another 8 cases) in the TF group. There was no major entry site 
complication in the TR group. Minor entry site complications were encountered in 35 patients 
(9%) in the TF group (small hematomas) and 6 patients (small hematoma) (4%) in the TR 
group (p <0.05). The lower arm hematoma was treated with local cooling, anti-inflammatory 
drugs. There was no occurance of compartment syndrome in the TR group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. TRANSRADIAL ANGIOPLASTY IN CAROTIDE ARTERY STENTING: The mean 
age of patients treated was 72 years. There were 14 males and 6 females. Seven patients were 
symptomatic (transient ischemic attacks (TIAs) and / or stroke and > 60% stenosis). Thirteen 
patients were asymptomatic but had high grade stenosis (> 80%) on computed tomographic 
angiography (CTA), magnetic resonance angiography (MRA) or conventional duplex 
ultrasonography. We did not exclude patients from TRA based on preoperative imaging. The 
patients had the following comorbidities: 65% were smokers, 30% were diabetic, 70% were 
hypertensive, 45% had coronary artery disease and 40% were hypercholesterolemic. (Table 1) 
Twelve patients had disease in the right carotid bifurcation. Eight patients also had a bovine 
arch. We had 16 patients with type I arch anatomy and 4 patients with type II arch anatomy. 
Table 3. Complications
Radial group 
(n =167)
Femoral group 
(n =372)
p value
MACE Death (%) 2 (1) 15 (4) NS
AMI (%) 3 (2) 16 (4) NS
Urgent CABG (%) 0 (0) 2 (1) NS
Re PCI (%) 2 (1) 8 (2) NS
Summary (%) 7 (4) 41 (11) <0.05
Access site Major Transfusion (%) 0 (0) 6 (2) NS
Vasular repair (%) 0 (0) 3 (1) NS
Prolonged 
hospitalisation (%)
0 (0) 10 (3) NS
Summary (%) 0 (0) 19 (5) <0.05 
Minor Haematoma (%) 6 (4) 35 (9) NS
Summary 
(%)
6 (4) 54 (15) <0.01
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We were able to successfully complete the carotid stenting procedure using transradial access 
in 18 out of 20 patients (90% technical success rate). The mean procedure time was 67 
minutes. We used one diagnostic catheter in 15 patients and 2 diagnostic catheters in 3. The 
mean fluoroscopy time was 17 minutes. One patient developed intense radial artery 
vasospasm that precluded passage of the guiding sheath. This patient was a seventy year old, 
diabetic male, who in retrospect, had calcinosis of the radial artery. After removal of the 7 Fr 
sheath, we were unable to palpate a radial pulse proximal to the puncture site, but, there was a 
Doppler signal in the palmar arch and no sign of hand ischemia. In the other patient, the left 
CCA was not able to be cannulated. This patient had a type I arch and despite three catheter 
exchanges we were unable to cannulate the orifice of the left CCA thus aborting the 
procedure. There were no peri-operative myocardial infarctions, strokes or TIAs or deaths 
(0/20). (Table 2) In the case, where radial artery spasm prevented completion of the 
procedure, the radial artery occluded postoperatively but the patient remained asymptomatic. 
All other patients had patent access arteries, clinically, at the time of discharge and at 30-day 
follow-up None of the patients developed access site haematoma requiring surgical 
evacuation. One patient had incapacitating pain requiring intravenous analgesia and all 
patients were ambulatory within two hours of intervention. There were no instances of 
peripheral nerve injury or digital ischemia. All patients were discharged home on the first 
postoperative day. 
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Table 1. Patient demographic data
(N) (%)
Symptomatic 7 35
Asymptomatic 13 65
Smoking 13 65
Diabetes 6 30
Hypertension 14 70
Coronary artery disease 9 45
Hypercholesterolemia 8 40
Right Carotid artery disease 12 60
Left Carotid artery disease 8 40
Bovine arch 4 20
Type I arch 16 80
Type II arch 4 20
N (%)
Stroke/TIA 0 0
Acute myocardial infraction 0 0
Radial artery occlusion 1 5
Incapacitating pain 1 5
Surgical haematoma 0 0
Mobilization in 2 hours 20 100
Table 2.  Postoperative outcomes
 
CONCLUSION 
 
SELECTION OF A TEST TO IDENTIFY SIGNIFICANT CORONARY STENOSIS 
1. CORONARY ANGIOGRAPHY FOR LM AND PROXIMAL LAD 
ASSESSMENT 
In many cases, the planar 2D silhouette of the arterial lumen may be unable to accurately 
define the severity of coronary stenosis, regardless of whether visual or quantitative methods 
are used. LM has unique anatomical features, which influences the visual and angiographic 
assessment of lesion severity (54-56). LM is a relatively short vessel, and diffuse disease 
(tubular lesions) often precludes identification of a normal reference segment, leading to 
underestimation of lesion severity by angiography. Furthermore, the LM is relatively large 
vessel, therefore non-parallel catheter alignment may lead to an apparent ostial lesion due to 
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contrast streaming, while the overlap of the left anterior descending and left circumflex ostia 
may obscure the LM bifurcation. Additionally, haziness is often the result of an eccentric 
plaque seen en face rather than in profile, leading to a reduced volume of contrast dye at the 
lesion site without producing a stenosis that is quantifiable angiographically. Several studies 
have shown a poor correlation between IVUS and QCA-derived lumen dimensions in patients 
with angiographically detected LM stenosis, demonstrating significant intraobserver as well 
as interobserver variability in the angiographic assessment of the LM (57).  
2. TTE RESTING DOPPLER VELOCITY 
Assessing borderline coronary stenosis is an ongoing challenge in invasive cardiology. The 
optimal techniques are IVUS and FFR measurements, however these techniques are 
extremely expensive, not widely available, and require special training. Non-invasive 
techniques like TEE or TTDE using a high frequency transducer are useful for noninvasive 
evaluation of flow velocity dynamics in the LM (25-28). Doppler-TTE is a simple, widely-
used, and noninvasive procedure that does not require lengthy preparation and post-
examination observation, therefore can be used for routine screening of patients with known 
ambiguous LM as adjunct to other invasive or non-invasive diagnostic modalities. The cut-off 
value of 112 cm/sec determined by the ROC analysis demonstrated a good sensitivity of PDV 
in recognizing hemodynamically significant (determined by IVUS) LM disease, however the 
specificity of the method was rather low. This can still generate further unnecessary invasive 
testing’s, therefore at this point the PDV cannot considered a standalone method in the 
evaluation process of the borderline LM narrowing’s. A possible clinical algorithm is given in 
figure 1 and a typical borderline LM case is presented in figure 2. Further, large scale studies 
are needed to establish the exact cut-off value of PDV for routine clinical application.  
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Figure 1. Left main coronary disease: diagnostic flow chart which incorporates the Doppler 
echocardiographic parameters. 
 
Figure 2. The imaging sequel of a 64-year old male patient with ambiguous angiography 
result. Coronary angiography revealed a tubular 30% stenosis of the LM, and non significant 
stenosis of the left and right coronary artery (panel A). However, the clinical presentation 
(severe angina, Canadian classification III-IV) did not corroborate with the angiographical 
findings, therefore the patient was sent to TTDE, which confirmed very high (272 cm/s) LM 
resting PDV (panel B). IVUS and FFR were performed, which both confirmed the severity of 
the LM stenosis (FFR=0.72; IVUS plaque burden: 65 % and LCSA: 4.6 mm2) (panel C-D)  
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SELECTION OF THE ACCESS FOR CORONARY AND PERIPHERAL 
INTERVETION 
1. CORONARY ANGIOPLASTY FOR STEMI 
The primary purpose of this study was to justify the safety and efficacy of transradial 
approach for PCI in STEMI patient subset. Louvard et al. reported the results of 
nonrandomized comparison of the radial and femoral approaches for primary PCI (58). The 
study included 1214 patients treated in two European centers; 267 patients (22%) were treated 
via a transradial approach; 947 patients were treated via the femoral approach with use of 
vascular closure system (Perclose) in 889 patients and manual compression in the remaining 
58 patients. Overall procedure time, procedural outcome and the rate of TIMI III flow (88-
91%) did not differ between the transradial and transfemoral approach. Conversion to a 
femoral approach was necessary in 2% of patients. Overall local bleeding complications only 
occured in patients treated via the femoral approach, whether or not the Perclose system was 
used: transfusion or surgery were required in 12 out of 947 (1%) patients. Saito et al. 
compared the TR and TF routes for primary PCI in a randomized study that included 77 
patients (59). Cardiogenic shock was present in 6 % of patients. The procedural success rate 
in the radial group (96%) did not differ from that in the femoral group (97%). In no patient 
from radial to a femoral approach required cross-over. Some studies have confirmed the 
applicability and potential advantages of TR access in this patient subset with good procedural 
outcome and low vascular complication rate (60-63). This study demonstrates that transradial 
PCI in ACS subset was safe and the primary success rate was the same, regardless of whether 
the procedure was performed from the femoral or radial approach. The most important 
difference between our TF and TR groups is that while the incidence of major access site 
complications was considerably high in the TF group (5%), we could not detect any of them 
following TR access. Cross over rate to femoral apporach was 5% in TR group due to 2 
severe radial artery spasm, 5 brachial artery tortuosity, 1 inadequate guiding back up. 
Aggressive antithrombotic therapy is very important in order to limit the occurrence of 
thrombotic complications during and after the procedure. Nevertheless, during transfemoral 
PCI this aggressive antithrombotic treatment is associated with a high risk of access site 
complications. Kiemenej et al. compare the results of transradial approach with the brachial 
and femoral approaches in randomized study (ACCESS study) (39). They found that although 
the vascular access site complication rate was not significantly lower after the transradial 
approach (0%) than the transfemoral (2%) or brachial approaches (2%) (p =0.05), however in 
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patients treated with the platelet GP IIb/IIIa inhibitor the missing major access site bleeding 
complications in the radial group, proved to be significantly less to the five occurrence (7%) 
in the femoral group (p =0.04) (62). Despite the improvement of access site management after 
transfemoral intervention with the advent of vascular closure devices, bleeding complication 
remains a great challenge (63) The radial artery is a superficial and compressible vessel that 
allows for effective hemostasis. The avoidance of site related complication in the TR group is 
extremely important in the ACS patient subset. Patient comfort is increased due to the ability 
to sit up and ambulate immediately after procedure. 
Limitations of TR access. The major limitations of TR technique is that the absence of radial 
pulse or an ischaemic Allen test must be considered as absolute contraindications. The radial 
artery spasm is a common problem and in most cases can be prevented with intra-arterial 
vasodilators and/or hydrophilic guidewires. Following the intra-arterial spasmolytic cocktail 
the occurance of the radial artery was infrequent in our patient cohort. Forearm compartment 
syndrome can be a serious complication, however with experienced access of the radial artery 
we can prevent it, and if it occurs, with a lower arm bandage can be treated effectively, and 
surgery is not necessary in the vast majority of the cases. Forearm compartement sysndrome 
was not observed in our study population despite aggressive anticoagulation of this study 
population. Radial artery occlusion is a rare complication but it has no clinical importance if 
the Allen test is positive (64). With a non occlusive pressure bandage after transradial 
intervention the occurace of the radial artery occlusion can be minimaized (65). The anatomic 
variations of the radial artery (radial artery loop, tortuous radial artery, small radial artery) can 
be clarified before the intervention with forearm echo examination but in this population, 
particularly in STEMI patients  there is not enough time to rule out the anatomical variations. 
Our data suggests that despite this potential anatomical problems with a careful guidewire 
insertion, with a low threshold of performing radial angiography, and in selected cases 
passing these anatomical obstacles with long hydrophilic sheath and hydrophilic wire we can 
solve these problems, and the routine echo examination is not neccessary (66). The small 
internal diameter of 6F catheters does not allow the use of some devices: debulking devices, 
embolic protective devices and the first-generation thrombus aspiration systems, but the 6F 
sheath can be changed to 7F or even 8F without any vascular complication (67). The recently 
used balloon catheters are compatible with 6F guiding catheters for kissing technique, 
however, in bifurcation lesions we can replace the 6F sheath with a 7F device, if necessary. 
Although the cannulation of the coronary arteries is easy from the right radial artery, an 
adequate backup support and coaxial alignment from the contralateral aortic wall is a 
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prerequisite for difficult situations. With using long-tip catheters such as AL, Voda we can 
solve difficult situations, as well. The learning curve is very important in patients with ACS, 
because more technical difficulties are associated with this approach. For this reason, patient 
selection is an important issue particularly for beginners who should select first time stable 
patients with good anatomical properties. With larger experience, operators could extend the 
indications of transradial access progressively to patients with unstable angina or with 
myocardial infarction. Study limitations. An important limitation of the study is the lack of 
the randomisation between the femoral and radial approach in consequence of the 
retrospective nature of the analysis. Another limitation is the lack of ultrasonic assessment of 
the radial artery before and after the procedure.  
2. CAROTIDE ARTERY STENTING 
Systematic reviews of observational studies provide considerable data to support the 
performance of CAS.(68) According to a publication by Burton and Lindsay (69) in which 
2992 patients were evaluated in 26 studies from 2002 to 2004, CAS is associated with an 
adverse event rate of 2.4% ± 0.3%, which is comparable to that of current carotid 
endarterectomy.(76) Most interventionists prefer to use the transfemoral approach for access. 
This method provides adequate access in most situations and allows traversal of the arch and 
negotiation of acute angles at the ostia of the great vessels. Femoral access is not possible in 
some patients. Extensive atherosclerotic disease in the aortic arch, atypical aortic arch 
anatomy, dissection of the thoracic aorta, iliofemoral occlusive disease, and infection in the 
groin are some of the limitations for femoral access. In such cases, alternate access sites need 
to be considered, such as transcervical, transbrachial, or transradial. The transcervical 
approach is more invasive because it usually requires a small cervical incision to prevent 
potentially disastrous access site complications and ensure hemostasis due to the lack of 
percutaneous carotid puncture closure systems at present. The transbrachial approach may 
also be difficult to perform and can result in severe complications, including brachial sheath 
hematoma, compartment syndrome, injury to the median nerve, or ischemia to the hand. (70) 
Major access site complications were more frequently encountered during coronary artery 
stenting (CAS) after transbrachial and transfemoral puncture compared with transradial access 
according to the Access study (39). Significant benefit in favor of transradial access was 
found in the multicenter randomized Access study comparing transfemoral, transbrachial, and 
transradial approaches for coronary artery stenting. Radial access was associated with fewer 
major complications (2.0% for transfemoral, 2.3% for transbrachial, 0% for transradial) and 
had the same technical success rate (91% to 92%) as transfemoral and transbrachial access. 
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Percutaneous transradial coronary angioplasty led to asymptomatic loss of the radial pulse in 
approximately 3% of patients. As carotid stenting devices become increasingly more pliable 
and lower in profile, the percentage of periprocedural radial artery occlusions is expected to 
decrease. The right transradial approach is particularly efficacious for cannulation of the right 
CCA or the left CCA in the presence of a bovine arch because it minimizes the risk of 
particulate embolization. The advantage of the right transradial approach is the avoidance of 
catheter manipulations in the aortic arch, because there is no need to negotiate the ostia of the 
arch vessels. The incidence of cerebral embolization during CAS procedures using a 
transfemoral approach was analyzed by Hammer et al. (71) Their study demonstrated that 
40% of the patients had new ischemic lesions in postoperative diffusionweighted MRI, and 
that 62% of the cases with positive diffusion-weighted MRI had embolic lesions that were 
found outside the vascular territory of the treated internal carotid artery, thus suggesting 
embolization from the aortic arch. Cannulation of the left CCA in patients with type I arch 
anatomy may be more difficult or impossible through the right radial artery. If this is the case, 
standard femoral access can be used for CAS procedure. We now perform preoperative CTA 
and MRA to evaluate aortic arch anatomy that might preclude successful transradial access. 
The use of the transradial approach for coronary angiography was first described by Lucien 
Campeau in 1989. (72) The safety and feasibility of this approach in coronary angioplasty and 
stenting have been reported in several studies. (73) As a consequence of these favorable initial 
results and reduced bleeding risk, despite use of potent antithrombotic and platelet therapy, 
transradial access for coronary intervention has gained widespread worldwide acceptance. 
Transradial access provides excellent postoper- ative comfort for the patient, with practically 
immediate ambulation after the procedure. Researchers have even found a cost reduction in 
several studies because of the low incidence of complications, no need for a closure devices, 
and reduced length of stay. Use of transradial access for CAS has been reported in sporadic 
case reports.(74) Despite excellent results, this method has not gained widespread acceptance. 
The reasons for the infrequent use of transradial access for CAS may have been the large, 
inflexible, first-generation stenting systems and sheaths. Devices have quickly been 
developed, however, that are hydrophilic, flexible, kink-resistant, and that have low profiles 
(5F to 6F). These technical improvements should facilitate use of TRA access. Further 
downsizing of carotid stents should theoretically allow most patients to accommodate the 
procedure through transradial access. Similar to every method in the beginning, the transradial 
access technique also has a learning curve. The puncture of this relatively small-caliber artery 
is not always easy. The radial artery is very vasoreactive and tends to spasm; therefore, it is 
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important to try to achieve entry on the first puncture. The radial artery has a small lumen, but 
its muscular wall dilates to accommodate 8F diameter sheaths (68). It is very important to 
administer spasmolytic medication (isosorbide dinitrate, lidocaine, or verapamil) intra-
arterially immediately after the puncture. This will decrease the incidence of vasospasm and 
radial artery occlusion from 60% to 3% (64). Periprocedural pain and paresthesias may be 
considerably reduced by the use of micropuncture systems to access the radial artery. 
Complications at the radial artery puncture site are extremely rare owing to the anatomy of the 
wrist. The median nerve courses apart from the artery in this location; therefore, it is almost 
impossible to cause an injury to the nerve. The artery lies very superficially on the radius; 
therefore, it is relatively easy to access and compress. Ease and effectiveness of 
compressibility are vital for interventions where patients have received anticoagulation 
medication. In cases of postoperative bleeding after radial access, patients are able to 
recognize and control the bleeding themselves. Even when the radial artery occludes, the hand 
is not jeopardized because of the dual blood supply through the ulnar artery and palmar arch. 
Most patients remained asymptomatic despite radial artery occlusion if they had a negative 
(normal) Allen’s test, and it is notable that the radial pulse had returned to normal at the 1-
month follow-up in half of the patients. A properly performed and documented Allen’s test is 
imperative before use of transradial access. The contraindications to use of transradial access 
are a nonpalpable radial pulse, a positive (abnormal) Allen’s test, calcinosis, and need to 
maintain the radial artery for dialysis access. Radial artery size and degree of calcinosis can 
be determined by preoperative duplex evaluation. In this pilot study, we did not perform 
duplex evaluation of our patients’ radial arteries; however, after further review of our results 
and the literature, we now recommend obtaining a duplex study to evaluate size and 
suitability of the radial artery before sheath insertion. Contrary to public perception, Saito et 
al (74 ) have published that there is no relationship between radial artery internal diameter and 
weight, height, or patient body sur surface area. Stella et al (64) also comment that there is no 
correlation between gender and postprocedural radial artery occlusion. We perform transradial 
access in patients with noncalcified arteries sized_2.5 mm duplex because that size will 
accommodate the outer diameter of a 6F sheath. 
CONCLUSIONS: Our early experience with transradial access confirms that CAS can be 
effectively performed through this approach with acceptable morbidity and with high 
technical success and patient satisfaction. We propose that transradial access is a safe, ideal 
alternative to transfemoral access and do not restrict its use just to patients with difficult 
femoral access. We preferentially perform CAS with transradial access in patients with right-
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sided carotid lesions and left-sided carotid lesions in the presence of bovine or type II or III 
arch anatomy (Fig 3.). We recommend obtaining imaging of the aortic arch and supra-aortic 
trunks with CTA and MRA, as well as a duplex scan of radial artery before attempting CAS 
when using transradial access. With this approach, patients with unfavorable aortic arch and 
radial artery characteristics that impact procedural success can be excluded. A multicenter, 
randomized, controlled trial is needed to definitively answer whether transradial access can 
replace transfemoral access routinely during CAS.  
Documented stenosis on duplex
High risk Good risk
CTA/MRA
Type I arch
Left-sided lesion
Type II / III arch 
Bovine  arch                   
and left-sided lesion 
Right-sided lesions
Allen´s test
Duplex exam of radial artery
Abnormal
< 2.5 mm RAID, calcinosis
Normal
>/= 2.5 mm RAID
Transfemoral CAS Transradial CAS CEA
Fig 3
 
 
3. RENAL ARTERY STENTING 
The typical access site for percutaneous angioplasty is the common femoral or brachial artery. 
We used a 7F sheath because renal artery stents need a 6F guiding sheath or a 7F guiding 
catheter. It should be noted that the renal artery may not be reached through the radial artery 
with a 90-cm guiding catheter, so a 120-cm guiding catheter must be used in tall patients 
 
 
 
NEW OBSERVATIONS 
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1.  Transthoracal Doppler echocardiography evaluation might be a useful adjunct to other 
invasive and non-invasive methods in the assessment of borderline left main lesions. 
LM TTDE gives additional functional information about LM stenosis severity. 
2. TEE-CFR measurement is appropriate for the non-invasive functional assessment of 
proximal LAD stenosis. We have found no significant correlations between 
angiography- and IVUS-defined stenosis in cases of borderline stenosis. TEE-CFR 
provides supplementary information on the functional severity of stenosis and its 
results relate better to the results of IVUS than to those of QCA. Our data also showed 
that the value of QCA-defined diameter stenosis is not significantly related to either 
the lumen cross-sectional area or the value of CFR. 
3. Transradial access for the treatment of ST elevation myocardial infarction is feasible 
and safe. The major advantages of the TR technique are the extremely low rate of 
vascular access complications, an improved comfort for the patient, a short 
hospitalisation with reduced hospital costs at a not increased procedural cost. Our 
results demonstrate that TR access for is effective treatment in this population subset 
and results in significantly less vascular complication rate than TF access. In 
experienced hands this technique in safe and efficacious. The lack of site related 
complications, and better patient comfort makes this technique the choice of 
preference in this high risk population. 
4. Early experience with transradial access, confirms that carotid artery stenting can be 
effectively performed through this approach with acceptable morbidity, as well as high 
technical success and patient satisfaction. We propose that TRA is a safe, ideal 
alternative to transfemoral access and do not restrict its use to patients with difficult 
femoral access. 
5. A radial approach can be successfully used for renal artery stenting, yet further studies 
are needed to assess the long term efficacy of this technique. The radial approach 
should be preferred in the presence of significant peripheral arterial occlusive disease 
and if the renal artery points downward.  
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ABBREVIATIONS:  
LMCA = Left main coronary artery  
LAD = left anterior descending artery 
TTE = transthoracal echocardiography 
TEE = transoesophageal echocardiography 
TTDE = transthoracic Doppler echocardiography 
PDV = peak diastolic velocity    
CFR = coronary flow reserve 
FFR = fractional flow reserve 
QCA = quantitative coronary angiography 
IVUS = intravascular ultrasound 
MLA = minimum lumen area 
DS = diameter stenosis 
PCI = percutaneous coronary intervention  
CTA= computer tomographic angiography 
PCI= percutaneous coronary intervention  
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